Australian scientists say it could also help reduce the risk of overdiagnosis by determining which cancers are low-risk and will never cause harm.

An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following ...

Scans that make prostate cancer cells glow can eliminate the need for invasive biopsies and cut false positive—and they're ...

The ongoing Daro-PET study set out to evaluate the ability of the oral androgen receptor inhibitor darolutamide (Nubeqa) to ...

The Foresight CLARITY test offers greater prognostic accuracy than PET/CT scans in large B-cell lymphoma by detecting ctDNA-MRD negativity, indicating better patient outcomes. ctDNA-MRD testing showed ...

Researchers have developed a tiny antibody that can find a common cancer protein and make tumors light up during PET scans. In tests with mice, tumors containing the protein EphA2 glowed clearly when ...

A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.

FDA approves Pylarify TruVu, a new prostate cancer PET imaging agent designed to expand access and improve detection of recurrent or metastatic disease.

A small veterinary laboratory in California, VDI Labs, is helping more animals survive through early cancer detection – their new biomarker test will aid veterinarians and dog owners in the quest to ...

Fortunately, a PET scan showed no evidence of cancer in Romano’s body. Still, her doctor recommended continuing with what she described as a “protocol,” which includes supplements, eight weeks of ...